The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of body mass index, diabetes, and tumor mutational burden in ovarian, fallopian tube, and primary peritoneal carcinoma with BRCA1/2 alteration on poly(ADP-ribose) polymerase inhibitors.
 
Ryan Tan
Stock and Other Ownership Interests - Abbott Laboratories (I); AstraZeneca (I); Becton Dickinson (I); Edwards Lifesciences (I); Intuitive Surgical (I); Johnson & Johnson/MedTech (I); Johnson & Johnson/MedTech (I); Medtronic (I)
Honoraria - Novartis
Travel, Accommodations, Expenses - Merck
 
Charlie White
No Relationships to Disclose
 
Yuan Chen
No Relationships to Disclose
 
Sherry Shen
Honoraria - MJH Life Sciences
Research Funding - Merck (Inst); Sermonix Pharmaceuticals (Inst)
 
Vicky Makker
Consulting or Advisory Role - ArQule; Clovis Oncology; DualityBio; Eisai; Faeth Therapeutics; GlaxoSmithKline; IBM; ITeos Therapeutics; Kartos Therapeutics; Karyopharm Therapeutics; Lilly; Merck; Novartis; Takeda
Research Funding - AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); DualityBio (Inst); Eisai (Inst); Faeth Therapeutics (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); Merck (Inst); Takeda (Inst); Zymeworks (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Eisai; ESMO Congress; Merck
Other Relationship - IBM
 
Mark Robson
Consulting or Advisory Role - OptumHealth
Research Funding - Artios (Inst); AstraZeneca (Inst); Merck (Inst)
Travel, Accommodations, Expenses - AstraZeneca
Other Relationship - Clinical Care Options; Clinical Education Alliance; MJH Healthcare Holdings, LLC; MyMedEd; Pfizer; Physicans' Education Resource; Research to Practice
(OPTIONAL) Uncompensated Relationships - Artios; Foundation Medicine; GlaxoSmithKline; Merck; Pfizer; Tempus; Zenith Pharmaceuticals
 
Neil Iyengar
Consulting or Advisory Role - AstraZeneca; BD Biosciences; Daiichi Sankyo/Lilly; Genentech/Roche; Gilead Sciences; Novartis; Pfizer; Seagen; SynDevRx; Tersera
Research Funding - American Cancer Society (Inst); Breast Cancer Research Foundation (Inst); Conquer Cancer Foundation (Inst); National Cancer Institute (Inst); Novartis (Inst); SynDevRx (Inst)